Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381929168> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4381929168 abstract "Abstract Background Primary cutaneous B‐cell lymphoma (PCBCL) is a group of B‐cell lymphomas of the skin containing primary cutaneous follicle centre lymphoma (PCFCL) and marginal zone B‐cell lymphoma/lymphoproliferative disorder (PCMZL), which are indolent, and diffuse large B‐cell lymphoma, leg type (PCDLBCL‐LT), which is aggressive. Objectives To evaluate treatment outcomes between PCBCL subtypes after treatment with rituximab and to compare the efficacy of intralesional against systemic rituximab in indolent subtypes. Methods A search for patients diagnosed with PCBCL and treated with rituximab (systemic or intralesional) across all Mayo Clinic sites was performed, yielding 39 patients. Results Eight patients had PCFCL (six treated intralesionally and two systemically), 11 had PCMZL (four intralesional, eight systemic with one dual‐treated) and 20 had PCDLBCL‐LT (all systemic). The average age at diagnosis was 62.1 years (SD = 15.1), with average follow‐up of 1852.6 days (SD = 1473.2). 69.2% of all patients treated with any form of rituximab experienced a complete response (100% PCFCL, 81.8% PCMZL and 50% PCDLBCL‐LT). When comparing all three subtypes, a significant difference was seen in overall treatment response ( p = 0.022), and progressive disease rates ( p = 0.015), but not in retreatment with rituximab ( p = 0.440), time to retreatment ( p = 0.757), recurrence ( p = 0.907) or survival ( p = 0.093). In the indolent subtypes, no difference in overall treatment response ( p = 1.000), progressive disease rates ( p = 1.000), recurrence ( p = 0.650), rituximab retreatment ( p = 0.650) or time to retreatment ( p = 0.724) was observed. Conclusions This study suggests that rituximab, as systemic therapy and intralesional therapy, is effective in the management of PCBCL, and that intralesional therapy should be considered before more aggressive therapy in indolent disease." @default.
- W4381929168 created "2023-06-25" @default.
- W4381929168 creator A5000617453 @default.
- W4381929168 creator A5011519591 @default.
- W4381929168 creator A5021666650 @default.
- W4381929168 creator A5033395766 @default.
- W4381929168 creator A5045021490 @default.
- W4381929168 creator A5051399808 @default.
- W4381929168 creator A5053985956 @default.
- W4381929168 creator A5063393328 @default.
- W4381929168 creator A5071053605 @default.
- W4381929168 creator A5073971261 @default.
- W4381929168 creator A5083035421 @default.
- W4381929168 creator A5090597445 @default.
- W4381929168 creator A5092255586 @default.
- W4381929168 date "2023-06-23" @default.
- W4381929168 modified "2023-10-17" @default.
- W4381929168 title "Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphoma" @default.
- W4381929168 cites W1925693065 @default.
- W4381929168 cites W1976541396 @default.
- W4381929168 cites W2025214085 @default.
- W4381929168 cites W2026420055 @default.
- W4381929168 cites W2096160655 @default.
- W4381929168 cites W2119178992 @default.
- W4381929168 cites W2121770885 @default.
- W4381929168 cites W2131366328 @default.
- W4381929168 cites W2139254223 @default.
- W4381929168 cites W2140314219 @default.
- W4381929168 cites W2760907988 @default.
- W4381929168 cites W2765386359 @default.
- W4381929168 cites W2783050754 @default.
- W4381929168 cites W2909964376 @default.
- W4381929168 cites W2911378996 @default.
- W4381929168 cites W3043099616 @default.
- W4381929168 cites W4303613823 @default.
- W4381929168 doi "https://doi.org/10.1002/jvc2.205" @default.
- W4381929168 hasPublicationYear "2023" @default.
- W4381929168 type Work @default.
- W4381929168 citedByCount "0" @default.
- W4381929168 crossrefType "journal-article" @default.
- W4381929168 hasAuthorship W4381929168A5000617453 @default.
- W4381929168 hasAuthorship W4381929168A5011519591 @default.
- W4381929168 hasAuthorship W4381929168A5021666650 @default.
- W4381929168 hasAuthorship W4381929168A5033395766 @default.
- W4381929168 hasAuthorship W4381929168A5045021490 @default.
- W4381929168 hasAuthorship W4381929168A5051399808 @default.
- W4381929168 hasAuthorship W4381929168A5053985956 @default.
- W4381929168 hasAuthorship W4381929168A5063393328 @default.
- W4381929168 hasAuthorship W4381929168A5071053605 @default.
- W4381929168 hasAuthorship W4381929168A5073971261 @default.
- W4381929168 hasAuthorship W4381929168A5083035421 @default.
- W4381929168 hasAuthorship W4381929168A5090597445 @default.
- W4381929168 hasAuthorship W4381929168A5092255586 @default.
- W4381929168 hasBestOaLocation W43819291681 @default.
- W4381929168 hasConcept C126322002 @default.
- W4381929168 hasConcept C142724271 @default.
- W4381929168 hasConcept C159654299 @default.
- W4381929168 hasConcept C203014093 @default.
- W4381929168 hasConcept C2776995267 @default.
- W4381929168 hasConcept C2777257650 @default.
- W4381929168 hasConcept C2778453870 @default.
- W4381929168 hasConcept C2779338263 @default.
- W4381929168 hasConcept C2779921676 @default.
- W4381929168 hasConcept C2780653079 @default.
- W4381929168 hasConcept C71924100 @default.
- W4381929168 hasConcept C90924648 @default.
- W4381929168 hasConceptScore W4381929168C126322002 @default.
- W4381929168 hasConceptScore W4381929168C142724271 @default.
- W4381929168 hasConceptScore W4381929168C159654299 @default.
- W4381929168 hasConceptScore W4381929168C203014093 @default.
- W4381929168 hasConceptScore W4381929168C2776995267 @default.
- W4381929168 hasConceptScore W4381929168C2777257650 @default.
- W4381929168 hasConceptScore W4381929168C2778453870 @default.
- W4381929168 hasConceptScore W4381929168C2779338263 @default.
- W4381929168 hasConceptScore W4381929168C2779921676 @default.
- W4381929168 hasConceptScore W4381929168C2780653079 @default.
- W4381929168 hasConceptScore W4381929168C71924100 @default.
- W4381929168 hasConceptScore W4381929168C90924648 @default.
- W4381929168 hasLocation W43819291681 @default.
- W4381929168 hasOpenAccess W4381929168 @default.
- W4381929168 hasPrimaryLocation W43819291681 @default.
- W4381929168 hasRelatedWork W1514589888 @default.
- W4381929168 hasRelatedWork W1971707885 @default.
- W4381929168 hasRelatedWork W1976991072 @default.
- W4381929168 hasRelatedWork W2003603592 @default.
- W4381929168 hasRelatedWork W2005862926 @default.
- W4381929168 hasRelatedWork W2072345784 @default.
- W4381929168 hasRelatedWork W2086036467 @default.
- W4381929168 hasRelatedWork W2094083392 @default.
- W4381929168 hasRelatedWork W2167253177 @default.
- W4381929168 hasRelatedWork W3196113865 @default.
- W4381929168 isParatext "false" @default.
- W4381929168 isRetracted "false" @default.
- W4381929168 workType "article" @default.